Phase 3 Varicella (Chickenpox) Clinical Trials

2 recruitingPhase 3

What is a Phase 3 trial?

Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.

Showing 1–2 of 2 trials

Recruiting

Phase 3

A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years

Varicella (Chickenpox)Chickenpox Vaccine

GC Biopharma Corp474 enrolled1 locationNCT07054099

Recruiting

Phase 3

Second Dose of Varicella Vaccine in Healthy Children

Varicella (Chickenpox)Varicella Immunisation

Sinovac (Dalian) Vaccine Technology Co., Ltd.300 enrolled5 locationsNCT07475000